As much of the world begins to reopen as COVID-19 cases are beginning to drop thanks to social distancing measures and the administering of the two vaccines, GWHP Corp recognizes that demand remains high for PPE supplies and COVID-19 diagnostic testing kits. Global WHoleHealth Partners is in a position where our partnerships with key players allow us to continually source and supply these in demand products. While we are hopeful that with the Pfizer and Moderna vaccines currently being distributed and administered COVID-19 cases will continue to drop, we recognize that demand is still high for these products.
With 2021 nearing the halfway point, travel is beginning to increase steadily and more and more states are beginning to relax their requirements. However, it is important for us to remember that we are still in the middle of a pandemic. The use of PPE supplies such as masks and gloves as well as taking COVID-19 tests when we believe to have been exposed is the safest way to navigate the pandemic and protect the at risk community.
Visit our medical supply page to view current offerings and get in touch with us to place your wholesale order of COVID-19 diagnostic testing kits and PPE supplies, call 877-568-4947. Global WholeHealth Partners stands committed to sourcing these in demand products for interested parties in wholesale capacities.
About Global WholeHealth Partners OTC (GWHP)
GWHP provides cutting edge technology using In-vitro Diagnostic (IVD) Real-Time PCR Machines that detect between 1 - 1 ½ hours and Rapid Diagnostic Testing (RDT) Serum Plasma that detect between 15 -20 minutes, which predict diseases ahead of its industry competitors. Our focus is encompassing, improving, and preserving the quality of life by providing fast, adequate and accurate test results to prompt early treatment and cut cost of accumulated diseases all over the world. By so doing, GWHP has led the fight against vector borne terminal diseases such as Ebola, ZIKA, Dengue, Malaria, Influenza and Tuberculosis, Corona Viruses, and among other vector borne diseases. MISSION GWHP is committed to building long term shareholder value through the vertical integration of proven, well established business that effectively and efficiently control disease outbreak and significantly reducing health care costs. VISION Our vision is to lead the industry in infectious disease diagnostics and provide molecular solutions that lessen the time to diagnose medical results, empower healthcare professionals to make better diagnostic decisions, and lower healthcare costs.